Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial-Reference-Cited by-同舟云学术

Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial

Published:2014-04-17 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Potthoff Karin,Habl Gregor,Bruckner Thomas,Suppan Christian,Hassel Jessica,Jäger Dirk,Indorf Martin,Debus Juergen

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-270.pdf

Reference30 articles.

1. Vecchione L, Jacobs B, Normanno N, Ciardiello F, Tejpar S: EGFR-targeted therapy. Exp Cell Res. 2011, 317 (19): 2765-71. 10.1016/j.yexcr.2011.08.021.

2. Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, Batra SK: Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012, 16 (1): 15-31. 10.1517/14728222.2011.648617.

3. Vallbohmer D, Lenz HJ: Epidermal growth factor receptor as a target for chemotherapy. Clin Colorectal Cancer. 2005, 5 (Suppl 1): S19-27.

4. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E: Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004, 351 (4): 337-45. 10.1056/NEJMoa033025.

5. Mendelsohn J, Baselga J: The EGF receptor family as targets for cancer therapy. Oncogene. 2000, 19 (56): 6550-65. 10.1038/sj.onc.1204082.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structured review of the patient-reported outcome instruments used in clinical trials in head and neck surgery;British Journal of Oral and Maxillofacial Surgery;2018-04

2. Toxicities of Immunotherapy for the Practitioner;Journal of Clinical Oncology;2015-06-20